bacteria | mecfa

MECFA Blog

Arch Scientist Publishes Data on the Pre-Clinical Efficacy of AB569 in Killing of Drug Resistant Bac

TORONTO, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., ("Arch" or the "Company") (TSXV:ARCH, OTCQB:ACHFF), announced today...

Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus

Staphylococcus aureus bacteria are a major cause of serious infections that often persist despite antibiotic treatment, but scientists at...

Lung damage bacteria sniffed out by dogs in cystic fibrosis research

A new study found the animals can detect ultra-low concentrations of pseudomonas, the commonest cause of lung infection in the disease....

Life-saving designer ‘NINJA virus’ hailed as medical breakthrough in curing infection

A VIRUS cocktail designed to seek and destroy bacteria has cleared a 15-year-old lung transplant patient of an antibiotic-resistant...

Phages, Viruses that Attack Bacteria, Are a Potential Therapy Against Infections, Case Report Sugges

The case report of a cystic fibrosis (CF) patient suggests that phages — viruses that naturally infect and kill bacteria — are a...

Large Sugar Molecule Disrupts B. cepacia Bacteria from CF Patients, Study Shows

An experimental large sugar molecule called poly (acetyl, arginyl) glucosamine, or PAAG, was able to disrupt treatment-resistant biofilms...

Virus that Infects Bacteria Turns Immune Response Away from P. aeruginosa, Study Shows

Pseudomonas aeruginosa, the most common bacteria found in cystic fibrosis (CF) patients, uses a virus to go unnoticed by the host immune...

New Method to Deliver Bacteria-killing Viruses Seen to Resolve Lung Infections in CF Mice

A new therapy which is administered directly into the lung of viruses can kill bacteria, and was shown to be effective in reducing...

Harmful Bacteria Replace Beneficial Ones in Gut of CF Patients, Study Finds

Cystic fibrosis (CF) patients have a higher amount of harmful gut bacteria and increased levels of intestinal inflammation than healthy...

Understanding How Bacteria ‘Talk’ Could Hold Key for New CF Treatments, Study Suggests

New research provides insights into how bacteria “talk” to each other in lung infections, which could provide strategies to block these...

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

A case for improved carrier screening

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

The search for molecular glue in targeted disease control

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p